Stock-Based Compensation for Insmed (INSM)
Stock-Based Compensation for Insmed (INSM): headline value $113.67M · YoY +57.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
INSM
Currently viewingStock-Based CompensationSwitch metric
Latest period
$113.67M
YoY change
+57.7%
5Y CAGR
+33.4%
Peak year (2025)
$152.71M
Latest annual
$152.71M
Stock-Based Compensation history chart for Insmed (INSM) from 1999 to 2025
Stock-Based Compensation history table for Insmed (INSM) from 1999 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $152.71M | +57.7% | ||
| 2024 | $96.83M | +29.5% | ||
| 2023 | $74.78M | +29.6% | ||
| 2022 | $57.69M | +25.3% | ||
| 2021 | $46.02M | +27.3% | ||
| 2020 | $36.16M | +34.1% | ||
| 2019 | $26.97M | +2.8% | ||
| 2018 | $26.24M | +45.2% | ||
| 2017 | $18.07M | +0.2% | ||
| 2016 | $18.04M | +15.7% | ||
| 2015 | $15.59M | +37.6% | ||
| 2014 | $11.33M | +30.7% | ||
| 2013 | $8.67M | +190.8% | ||
| 2012 | $2.98M | +86.4% | ||
| 2011 | $1.60M | +336.9% | ||
| 2010 | $366,000 | -85.6% | ||
| 2009 | $2.54M | +199.1% | ||
| 2008 | $850,000 | +63.1% | ||
| 2007 | $521,000 | -41.1% | ||
| 2006 | $885,000 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | -100.0% | ||
| 2002 | $95,000 | 0.0% | ||
| 2001 | $95,000 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — |
Stock-Based Compensation values are taken from Insmed's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Insmed (INSM) stock-based compensation totalled $152.71M – surged 57.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Insmed stock-based compensation compounded at +33.4% per year, with the latest reading among the more recent periods of the dataset.
The dataset's maximum stock-based compensation sits at $152.71M (2025); the minimum reading of $0 dates to 1999.
Insmed (INSM) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.
Insmed Stock-Based Compensation by Year
Insmed Stock-Based Compensation 2025: $152.71M
Insmed stock-based compensation in 2025 was $152.71M, surged 57.7% from 2024. This figure represents the highest annual value in the available history.
Insmed Stock-Based Compensation 2024: $96.83M
Insmed stock-based compensation in 2024 was $96.83M, grew 29.5% from 2023.
Insmed Stock-Based Compensation 2023: $74.78M
Insmed stock-based compensation in 2023 was $74.78M, grew 29.6% from 2022.
Insmed Stock-Based Compensation 2022: $57.69M
Insmed stock-based compensation in 2022 was $57.69M, grew 25.3% from 2021.
Insmed Stock-Based Compensation 2021: $46.02M
Insmed stock-based compensation in 2021 was $46.02M.
See more financial history for Insmed (INSM).
Sector peers — Stock-Based Compensation
Companies in the same sector as Insmed, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Insmed's stock-based compensation?
Latest reported stock-based compensation for Insmed (INSM) is $113.67M (period ending December 31, 2025).
How has Insmed stock-based compensation changed year-over-year?
Insmed (INSM) stock-based compensation changed +57.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Insmed stock-based compensation?
Insmed (INSM) stock-based compensation compound annual growth rate is +33.4% over the most recent 5 years available.
When did Insmed stock-based compensation hit its highest annual value?
Insmed stock-based compensation reached its highest annual value of $152.71M in 2025.
What was Insmed stock-based compensation in 2024?
Insmed (INSM) stock-based compensation in 2024 was $96.83M.
What was Insmed stock-based compensation in 2025?
Insmed (INSM) stock-based compensation in 2025 was $152.71M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
INSM Overview
Company profile, financial tools, and key metrics
INSM Revenue Counter
Earns $19.23 every second. See per minute, hour, and day.
INSM Earnings Counter
Loses −$40.49 per second. See per minute, hour, and day.
INSM Economic Scale
Exceeds Micronesia, Fed. Sts.'s GDP. Compare with world economies.
INSM What If Invested
What if you had invested $1,000? See historical returns from any date.
INSM How It Makes Money
Discover visual breakdown of $606.42M in revenue — where it comes from and where it goes.
INSM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INSM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INSM Daily Price Character
Explosive · 46.7% historical win rate (green days). Streaks & record days.
INSM Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.
INSM Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.